Summary & Overview
CPT 90740: Hepatitis B Vaccine for Immunosuppressed and Dialysis Patients
CPT code 90740 represents an intramuscular hepatitis B vaccine product formulated for patients who are immunosuppressed or receiving dialysis and is given as a three-dose series. This vaccine plays a critical role in preventing hepatitis B infection among high-risk populations who may have an attenuated immune response and require tailored dosing. Nationally, immunization of these groups reduces morbidity from chronic liver disease and limits transmission within healthcare settings.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for 90740, typical sites of service, and the population it targets. The publication also provides benchmarking information where available, common billing and coding considerations, and summaries of recent policy updates that affect coverage and administration practices. Where specific input data is missing, the text notes that information is not available in the input. The content is intended to inform billing staff, compliance officers, and clinical administrators about how CPT code 90740 is used in practice and what issues commonly arise when vaccinating immunosuppressed or dialysis patients.
Billing Code Overview
CPT code 90740 describes an intramuscular hepatitis B vaccine formulation intended for patients who are immunosuppressed or are undergoing dialysis. The vaccine is administered on a three-dose schedule to provide active immunization against hepatitis B virus, a liver infection that can lead to chronic disease.
Service Type: Vaccine administration / Immunization
Typical Site of Service: Outpatient clinics, dialysis centers, physician offices, and other ambulatory care settings
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult undergoing hemodialysis or receiving immunosuppressive therapy who requires the Hepatitis B vaccine series using the higher-dose or specialized formulation for immunocompromised or dialysis patients. The patient presents to an outpatient dialysis unit, primary care clinic, or community health center. The clinical workflow includes verification of prior Hepatitis B immunization status and serology (HBsAg, anti-HBs), informed consent, medication reconciliation for bleeding risk, and screening for acute illness or allergy. The licensed nurse prepares the 90740 vaccine and administers it intramuscularly (typically into the deltoid); documentation includes vaccine lot number, expiration, manufacturer, site and route of administration, VIS date, and adverse event counseling. Scheduling for the next dose in the three-dose series is arranged per immunization schedule adjusted for dialysis/immunosuppressed patients. Billing is submitted using 90740 with applicable modifier(s) reflecting the context of the encounter and any billing peculiarities (for example, professional vs technical components or payer-specific requirements).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Use when no other modifier applies to the service. |